Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| ClearPoint Neuro Inc | CLPT | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 5.42 | 06:37:02 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 5.42 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 4.05 - 9.98 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 5.42 | USD |
ClearPoint Neuro Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 138.39M | 26.98M | - | 23.96M | -22.09M | -0.82 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
ClearPoint Neuro News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CLPT Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 5.365 | 5.6341 | 5.105 | 5.34 | 132,104 | 0.055 | 1.03% |
| 1 Month | 6.61 | 6.71 | 5.105 | 5.66 | 115,074 | -1.19 | -18.00% |
| 3 Months | 6.99 | 7.97 | 5.105 | 6.49 | 160,508 | -1.57 | -22.46% |
| 6 Months | 5.88 | 7.97 | 4.05 | 6.45 | 130,980 | -0.46 | -7.82% |
| 1 Year | 9.98 | 9.98 | 4.05 | 6.46 | 134,033 | -4.56 | -45.69% |
| 3 Years | 20.525 | 22.80 | 4.05 | 12.09 | 175,664 | -15.11 | -73.59% |
| 5 Years | 5.60 | 31.29 | 2.8601 | 13.39 | 176,917 | -0.18 | -3.21% |
ClearPoint Neuro Description
| MRI Interventions Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. It has two product platforms: ClearPoint system, which is in commercial use in the United States, is used to perform minimally invasive surgical procedures in the brain and ClearTrace system, which is under development, to be used to perform minimally invasive surgical procedures in the heart. The company's products and product candidates include ClearPoint Neuro Intervention System and The ClearTrace Cardiac Intervention System. |
